Association of the habitual dietary intake with the fatty liver index and effect modification by metabotypes in the population-based KORA-Fit study.

Carbohydrates Diet Fatty liver index Food groups Metabotype

Journal

Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696

Informations de publication

Date de publication:
04 Apr 2024
Historique:
received: 26 02 2024
accepted: 26 03 2024
medline: 5 4 2024
pubmed: 5 4 2024
entrez: 4 4 2024
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is an emerging threat for public health with diet being a major risk factor in disease development and progression. However, the effects of habitual food consumption on fatty liver are still inconclusive as well as the proposed role of the individuals' metabolic profiles. Therefore, the aim of our study is to examine the associations between diet and NAFLD with an emphasis on the influence of specific metabotypes in the general population. A total of 689 participants (304 men and 385 women) of the KORA-Fit (S4) survey, a follow-up study of the population-based KORA cohort study running in the Region of Augsburg, Germany, were included in this analysis. Dietary information was derived from repeated 24-h food lists and a food frequency questionnaire. The intake of energy and energy-providing nutrients were calculated using the national food composition database. The presence of fatty liver was quantified by the fatty liver index (FLI), and metabotypes were calculated using K-means clustering. Multivariable linear regression models were used for the analysis of habitual food groups and FLI; for the evaluation of macronutrients, energy substitution models were applied. A higher consumption of nuts and whole grains, and a better diet quality (according to Alternate Healthy Eating Index and Mediterranean Diet Score) were associated with lower FLI values, while the intake of soft drinks, meat, fish and eggs were associated with a higher FLI. The isocaloric substitution of carbohydrates with polyunsaturated fatty acids was associated with a decreased FLI, while substitution with monounsaturated fatty acids and protein showed increased FLI. Statistically significant interactions with the metabotype were observed for most food groups. The consumption of plant-based food groups, including nuts and whole grains, and diet quality, were associated with lower FLI values, whereas the intake of soft drinks and products of animal origin (meat, fish, eggs) were associated with a higher FLI. The observed statistically significant interactions with the metabotype for most food groups could help to develop targeted prevention strategies on a population-based level if confirmed in independent prospective studies.

Sections du résumé

BACKGROUND BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) is an emerging threat for public health with diet being a major risk factor in disease development and progression. However, the effects of habitual food consumption on fatty liver are still inconclusive as well as the proposed role of the individuals' metabolic profiles. Therefore, the aim of our study is to examine the associations between diet and NAFLD with an emphasis on the influence of specific metabotypes in the general population.
METHODS METHODS
A total of 689 participants (304 men and 385 women) of the KORA-Fit (S4) survey, a follow-up study of the population-based KORA cohort study running in the Region of Augsburg, Germany, were included in this analysis. Dietary information was derived from repeated 24-h food lists and a food frequency questionnaire. The intake of energy and energy-providing nutrients were calculated using the national food composition database. The presence of fatty liver was quantified by the fatty liver index (FLI), and metabotypes were calculated using K-means clustering. Multivariable linear regression models were used for the analysis of habitual food groups and FLI; for the evaluation of macronutrients, energy substitution models were applied.
RESULTS RESULTS
A higher consumption of nuts and whole grains, and a better diet quality (according to Alternate Healthy Eating Index and Mediterranean Diet Score) were associated with lower FLI values, while the intake of soft drinks, meat, fish and eggs were associated with a higher FLI. The isocaloric substitution of carbohydrates with polyunsaturated fatty acids was associated with a decreased FLI, while substitution with monounsaturated fatty acids and protein showed increased FLI. Statistically significant interactions with the metabotype were observed for most food groups.
CONCLUSION CONCLUSIONS
The consumption of plant-based food groups, including nuts and whole grains, and diet quality, were associated with lower FLI values, whereas the intake of soft drinks and products of animal origin (meat, fish, eggs) were associated with a higher FLI. The observed statistically significant interactions with the metabotype for most food groups could help to develop targeted prevention strategies on a population-based level if confirmed in independent prospective studies.

Identifiants

pubmed: 38575962
doi: 10.1186/s12944-024-02094-0
pii: 10.1186/s12944-024-02094-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

99

Informations de copyright

© 2024. The Author(s).

Références

World Gastroentorology Organisation. WGO Practice Guideline NAFLD & NASH. Available online: https://www.worldgastroenterology.org/guidelines/nafld-nash . Accessed 29 Dec 2023.
David K, Kowdley KV, Unalp A, Kanwal F, Brunt EM, Schwimmer JB. Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:1904–12.
doi: 10.1002/hep.22868 pubmed: 19434741
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–47.
doi: 10.1097/HEP.0000000000000004 pubmed: 36626630
Lazarus JV, Mark HE, Villota-Rivas M, Palayew A, Carrieri P, Colombo M, Ekstedt M, Esmat G, George J, Marchesini G, et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? J Hepatol. 2022;76:771–80.
doi: 10.1016/j.jhep.2021.10.025 pubmed: 34895743
Younossi ZM, Corey KE, Lim JK. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 2021;160:912–8.
doi: 10.1053/j.gastro.2020.11.051 pubmed: 33307021
Pugliese N, Plaz Torres MC, Petta S, Valenti L, Giannini EG, Aghemo A. Is there an “ideal” diet for patients with NAFLD? Eur J Clin Invest. 2022;52:e13659.
doi: 10.1111/eci.13659 pubmed: 34309833
Bechthold A, Wendt I, Laubach B, Mayerböck C, Oberritter H, Nöthlings U. Consumers’ awareness of food-based dietary guidelines in Germany. Ernährungs Umschau. 2017;64:112–9.
Muriel P, López-Sánchez P, Ramos-Tovar E. Fructose and the liver. Int J Mol Sci. 2021;22:6969.
pmcid: 8267750 doi: 10.3390/ijms22136969 pubmed: 34203484
Montemayor S, García S, Monserrat-Mesquida M, Tur JA, Bouzas C. Dietary patterns, foods, and nutrients to ameliorate non-alcoholic fatty liver disease: a scoping review. Nutrients. 2023;15:3987.
pmcid: 10534915 doi: 10.3390/nu15183987 pubmed: 37764771
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
pmcid: 1636651 doi: 10.1186/1471-230X-6-33 pubmed: 17081293
Hillesheim E, Brennan L. Metabotyping and its role in nutrition research. Nutr Res Rev. 2020;33:33–42.
doi: 10.1017/S0954422419000179 pubmed: 31434587
Gutiérrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021;22:11629.
pmcid: 8583943 doi: 10.3390/ijms222111629 pubmed: 34769060
Holle R, Happich M, Löwel H, Wichmann HE. KORA–a research platform for population based health research. Gesundheitswesen. 2005;67(Suppl 1):S19-25.
doi: 10.1055/s-2005-858235 pubmed: 16032513
The Research Institute of the McGill University Health Centre Cooperative Health Research in the Augsburg Region. https://www.maelstrom-research.org/study/kora . Accessed 01 Sep 2023.
Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002;162:82–9.
doi: 10.1001/archinte.162.1.82 pubmed: 11784224
Zahn K, Linseisen J, Heier M, Peters A, Thorand B, Nairz F, Meisinger C. Body fat distribution and risk of incident ischemic stroke in men and women aged 50 to 74 years from the general population. The KORA Augsburg cohort study. PLoS One. 2018;13:e0191630.
pmcid: 5798769 doi: 10.1371/journal.pone.0191630 pubmed: 29401461
Peters A, Döring A, Ladwig KH, Meisinger C, Linkohr B, Autenrieth C, Baumeister SE, Behr J, Bergner A, Bickel H, et al. Multimorbidity and successful aging: the population-based KORA-Age study. Z Gerontol Geriatr. 2011;44(Suppl 2):41–54.
doi: 10.1007/s00391-011-0245-7 pubmed: 22270973
Freese J, Feller S, Harttig U, Kleiser C, Linseisen J, Fischer B, Leitzmann MF, Six-Merker J, Michels KB, Nimptsch K, et al. Development and evaluation of a short 24-h food list as part of a blended dietary assessment strategy in large-scale cohort studies. Eur J Clin Nutr. 2014;68:324–9.
doi: 10.1038/ejcn.2013.274 pubmed: 24398637
Illner AK, Harttig U, Tognon G, Palli D, Salvini S, Bower E, Amiano P, Kassik T, Metspalu A, Engeset D, et al. Feasibility of innovative dietary assessment in epidemiological studies using the approach of combining different assessment instruments. Public Health Nutr. 2011;14:1055–63.
doi: 10.1017/S1368980010003587 pubmed: 21385523
Mitry P, Wawro N, Six-Merker J, Zoller D, Jourdan C, Meisinger C, et al. Usual dietary intake estimation based on a combination of repeated 24-H food lists and a food frequency questionnaire in the KORA FF4 cross-sectional study. Front Nutr. 2019;6:145.
pmcid: 6743021 doi: 10.3389/fnut.2019.00145 pubmed: 31552261
Slimani N, Deharveng G, Charrondière RU, van Kappel AL, Ocké MC, Welch A, Lagiou A, van Liere M, Agudo A, Pala V, et al. Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition. Comput Methods Programs Biomed. 1999;58:251–66.
doi: 10.1016/S0169-2607(98)00088-1 pubmed: 10094230
Wawro N, Pestoni G, Riedl A, Breuninger TA, Peters A, Rathmann W, et al. Association of dietary patterns and Type-2 diabetes mellitus in metabolically homogeneous subgroups in the KORA FF4 study. Nutrients. 2020;12:1684.
pmcid: 7352280 doi: 10.3390/nu12061684 pubmed: 32516903
Tsivgoulis G, Judd S, Letter AJ, Alexandrov AV, Howard G, Nahab F, Unverzagt FW, Moy C, Howard VJ, Kissela B, Wadley VG. Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology. 2013;80:1684–92.
pmcid: 3716473 doi: 10.1212/WNL.0b013e3182904f69 pubmed: 23628929
Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, et al. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2018;68:361–71.
doi: 10.1002/hep.29724 pubmed: 29222911
Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, et al. Sex- and age-related differences in the contribution of ultrasound-measured visceral and subcutaneous abdominal fat to fatty liver index in overweight and obese caucasian adults. Nutrients. 2019;11:3008.
pmcid: 6950624 doi: 10.3390/nu11123008 pubmed: 31835303
Riedl A, Wawro N, Gieger C, Meisinger C, Peters A, Roden M, Kronenberg F, Herder C, Rathmann W, Völzke H, et al. Identification of Comprehensive Metabotypes Associated with Cardiometabolic Diseases in the Population-Based KORA Study. Mol Nutr Food Res. 2018;62:e1800117.
doi: 10.1002/mnfr.201800117 pubmed: 29939495
Riedl A, Wawro N, Gieger C, Meisinger C, Peters A, Rathmann W, Koenig W, Strauch K, Quante AS, Thorand B, et al. Modifying effect of metabotype on diet-diabetes associations. Eur J Nutr. 2020;59:1357–69.
doi: 10.1007/s00394-019-01988-5 pubmed: 31089867
Dahal C, Wawro N, Meisinger C, Breuninger TA, Thorand B, Rathmann W, et al. Optimized metabotype definition based on a limited number of standard clinical parameters in the population-based KORA study. Life (Basel). 2022;12:1460.
pmcid: 9604647 pubmed: 36294895
Zhang S, Yan Y, Meng G, Zhang Q, Liu L, Wu H, Gu Y, Wang X, Zhang J, Sun S, et al. Protein foods from animal sources and risk of nonalcoholic fatty liver disease in representative cohorts from North and South China. J Intern Med. 2023;293:340–53.
doi: 10.1111/joim.13586 pubmed: 36433820
Cardoso BR, Tan SY, Daly RM, Via JD, Georgousopoulou EN, George ES. Intake of Nuts and Seeds Is Associated with a Lower Prevalence of Nonalcoholic Fatty Liver Disease in US Adults: Findings from 2005–2018 NHANES. J Nutr. 2021;151:3507–15.
doi: 10.1093/jn/nxab253 pubmed: 34522969
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;393:1958–72.
Wang T, Masedunskas A, Willett WC, Fontana L. Vegetarian and vegan diets: benefits and drawbacks. Eur Heart J. 2023;44:3423–39.
pmcid: 10516628 doi: 10.1093/eurheartj/ehad436 pubmed: 37450568
Zhu Y, Yang H, Zhang Y, Rao S, Mo Y, Zhang H, Liang S, Zhang Z, Yang W. Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity. Front Public Health. 2022;10:1038435.
doi: 10.3389/fpubh.2022.1038435 pubmed: 36684870
Haigh L, Kirk C, El Gendy K, Gallacher J, Errington L, Mathers JC, Anstee QM. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis. Clin Nutr. 2022;41:1913–31.
doi: 10.1016/j.clnu.2022.06.037 pubmed: 35947894
Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, Plauth M. ESPEN practical guideline: Clinical nutrition in liver disease. Clin Nutr. 2020;39:3533–62.
doi: 10.1016/j.clnu.2020.09.001 pubmed: 33213977
Ivancovsky-Wajcman D, Fliss-Isakov N, Grinshpan LS, Salomone F, Lazarus JV, Webb M, et al. High meat consumption is prospectively associated with the risk of non-alcoholic fatty liver disease and presumed significant fibrosis. Nutrients. 2022;14:3533.
pmcid: 9459934 doi: 10.3390/nu14173533 pubmed: 36079791
He K, Li Y, Guo X, Zhong L, Tang S. Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br J Nutr. 2020;124:1–13.
pmcid: 7512147 doi: 10.1017/S0007114520000914 pubmed: 32138796
Zheng Q, Wu Y, Ye Q, Li J, Zhao Y. Relation between dietary iron intake and nonalcoholic fatty liver disease. Wei Sheng Yan Jiu. 2015;44:527–31.
pubmed: 26454945
Yin M, Chen S, Sun Y, Feng B, Lan Y, Wu S, Wang L. Egg consumption and non-alcoholic fatty liver disease: a prospective cohort study. Wei Sheng Yan Jiu. 2023;52:362–8.
pubmed: 37500513
Mazidi M, Mikhailidis DP, Banach M. Adverse impact of egg consumption on fatty liver is partially explained by cardiometabolic risk factors: A population-based study. Clin Nutr. 2020;39:3730–5.
doi: 10.1016/j.clnu.2020.03.035 pubmed: 32928581
Tan LJ, Shin S. Effects of oily fish and its fatty acid intake on non-alcoholic fatty liver disease development among South Korean adults. Front Nutr. 2022;9:876909.
pmcid: 9353947 doi: 10.3389/fnut.2022.876909 pubmed: 35938102
Dai W, Liu H, Zhang T, Chang Q, Zhao Y, Guo C, Xia Y. Dairy product consumption was associated with a lower likelihood of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Front Nutr. 2023;10:1119118.
pmcid: 9992538 doi: 10.3389/fnut.2023.1119118 pubmed: 36908921
Europäische Markbeobachtungsstelle für Fischerei- und Aquakulturerzeugnisse: Der EU-Fischmarkt. 2023.
Chung S, Hwang JT, Joung H, Shin S. Associations of Meat and Fish/Seafood Intake with All-Cause and Cause-Specific Mortality from Three Prospective Cohort Studies in Korea. Mol Nutr Food Res. 2023;67:e2200900.
doi: 10.1002/mnfr.202200900 pubmed: 37366293
Nseir W, Nassar F, Assy N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16:2579–88.
pmcid: 2880768 doi: 10.3748/wjg.v16.i21.2579 pubmed: 20518077
Lundsgaard AM, Bojsen-Møller KN, Kiens B. Dietary Regulation of Hepatic Triacylglycerol Content-the Role of Eucaloric Carbohydrate Restriction with Fat or Protein Replacement. Adv Nutr. 2023;14:1359–73.
pmcid: 10721463 doi: 10.1016/j.advnut.2023.08.005 pubmed: 37591342
Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr. 2012;95:1003–12.
doi: 10.3945/ajcn.111.030114 pubmed: 22492369
Rosqvist F, Iggman D, Kullberg J, Cedernaes J, Johansson HE, Larsson A, Johansson L, Ahlström H, Arner P, Dahlman I, Risérus U. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes. 2014;63:2356–68.
doi: 10.2337/db13-1622 pubmed: 24550191
Errazuriz I, Dube S, Slama M, Visentin R, Nayar S, O’Connor H, Cobelli C, Das SK, Basu A, Kremers WK, et al. Randomized Controlled Trial of a MUFA or Fiber-Rich Diet on Hepatic Fat in Prediabetes. J Clin Endocrinol Metab. 2017;102:1765–74.
pmcid: 5443322 doi: 10.1210/jc.2016-3722 pubmed: 28323952
Bortolotti M, Maiolo E, Corazza M, Van Dijke E, Schneiter P, Boss A, Carrel G, Giusti V, Lê KA, Quo Chong DG, et al. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin Nutr. 2011;30:494–8.
doi: 10.1016/j.clnu.2011.01.006 pubmed: 21288612
Markova M, Pivovarova O, Hornemann S, Sucher S, Frahnow T, Wegner K, Machann J, Petzke KJ, Hierholzer J, Lichtinghagen R, et al. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes. Gastroenterology. 2017;152:571-585.e578.
doi: 10.1053/j.gastro.2016.10.007 pubmed: 27765690
Tian A, Sun Z, Zhang M, Li J, Pan X, Chen P. Associations between dietary fatty acid patterns and non-alcoholic fatty liver disease in typical dietary population: A UK biobank study. Front Nutr. 2023;10:1117626.
pmcid: 9942598 doi: 10.3389/fnut.2023.1117626 pubmed: 36824175
Lang S, Martin A, Farowski F, Wisplinghoff H, Vehreschild M, Liu J, Krawczyk M, Nowag A, Kretzschmar A, Herweg J, et al. High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD. Hepatol Commun. 2020;4:681–95.
pmcid: 7193126 doi: 10.1002/hep4.1509 pubmed: 32363319
Max-Rubner-Institute: Ergebnisbericht, Teil 2, Nationale Verzehrsstudie II. 2008.
Linseisen J, Welch AA, Ocké M, Amiano P, Agnoli C, Ferrari P, Sonestedt E, Chajès V, Bueno-de-Mesquita HB, Kaaks R, et al. Dietary fat intake in the European Prospective Investigation into Cancer and Nutrition: results from the 24-h dietary recalls. Eur J Clin Nutr. 2009;63(Suppl 4):S61-80.
doi: 10.1038/ejcn.2009.75 pubmed: 19888281
Little TJ, Horowitz M, Feinle-Bisset C. Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr. 2007;86:531–41.
doi: 10.1093/ajcn/86.3.531 pubmed: 17823414
Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol. 2014;20:16649–64.
pmcid: 4248209 doi: 10.3748/wjg.v20.i44.16649 pubmed: 25469034
Young S, Tariq R, Provenza J, Satapathy SK, Faisal K, Choudhry A, Friedman SL, Singal AK. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis. Hepatol Commun. 2020;4:953–72.
pmcid: 7327210 doi: 10.1002/hep4.1519 pubmed: 32626829
Moazzami AA, Shrestha A, Morrison DA, Poutanen K, Mykkänen H. Metabolomics reveals differences in postprandial responses to breads and fasting metabolic characteristics associated with postprandial insulin demand in postmenopausal women. J Nutr. 2014;144:807–14.
doi: 10.3945/jn.113.188912 pubmed: 24717363
O’Sullivan A, Gibney MJ, Connor AO, Mion B, Kaluskar S, Cashman KD, Flynn A, Shanahan F, Brennan L. Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res. 2011;55:679–90.
doi: 10.1002/mnfr.201000458 pubmed: 21240901
O’Donovan CB, Walsh MC, Nugent AP, McNulty B, Walton J, Flynn A, Gibney MJ, Gibney ER, Brennan L. Use of metabotyping for the delivery of personalised nutrition. Mol Nutr Food Res. 2015;59:377–85.
doi: 10.1002/mnfr.201400591 pubmed: 25410729
Hillesheim E, Brennan L. Distinct patterns of personalised dietary advice delivered by a metabotype framework similarly improve dietary quality and metabolic health parameters: secondary analysis of a randomised controlled trial. Front Nutr. 2023;10:1282741.
pmcid: 10684740 doi: 10.3389/fnut.2023.1282741 pubmed: 38035361

Auteurs

M Schepp (M)

University of Augsburg, University Hospital Augsburg, EpidemiologyAugsburg, Germany. m.schepp@stud.uni-heidelberg.de.

D Freuer (D)

University of Augsburg, University Hospital Augsburg, EpidemiologyAugsburg, Germany.

N Wawro (N)

University of Augsburg, University Hospital Augsburg, EpidemiologyAugsburg, Germany.
Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

A Peters (A)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Chair of Epidemiology, Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.

M Heier (M)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
KORA Study Centre, University Hospital Augsburg, Augsburg, Germany.

D Teupser (D)

Institute of Laboratory Medicine, University Hospital, LMU Munich, Munich, Germany.

C Meisinger (C)

University of Augsburg, University Hospital Augsburg, EpidemiologyAugsburg, Germany.

J Linseisen (J)

University of Augsburg, University Hospital Augsburg, EpidemiologyAugsburg, Germany.
Institute for Medical Information Processing, Biometry and Epidemiology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.

Classifications MeSH